47. Buerger disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 9 / Drugs : 14 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 16
Buerger disease and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 47 | Buerger disease | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 6.000 |
| 51 | Scleroderma | 4.204 |
| 84 | Sarcoidosis | 2.732 |
| 85 | Idiopathic interstitial pneumonia | 2.721 |
| 88 | Chronic thromboembolic pulmonary hypertension | 1.846 |
| 210 | Single Ventricle | 1.641 |
| 41 | Giant cell arteritis | 1.636 |
| 70 | Spinal stenosis | 1.568 |
| 86 | Pulmonary arterial hypertension | 1.545 |
| 2 | Amyotrophic lateral sclerosis | 1.526 |
| 46 | Malignant rheumatoid arthritis | 1.524 |
| 211 | Hypoplastic left heart syndrome | 1.200 |
| 212 | Tricuspid atresia | 1.000 |
| 317 | Trifunctional protein deficiency | 1.000 |